Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR

Journal of Investigative Dermatology

Volumn 134, Issue 10, 2014, Pages 2570-2578

  Campbell, Patrick ^a   Morton, Penny E ^b   Takeichi, Takuya ^a,c   Salam, Amr ^a   Roberts, Nerys ^d   Proudfoot, Laura E ^a   Mellerio, Jemima E ^a,e   Aminu, Kingi ^d   Wellington, Cheryl ^d   Patil, Sachin N ^d   Akiyama, Masashi ^c   Liu, Lu ^f   McMillan, James R ^f   Aristodemou, Sophia ^f   Ishida Yamamoto, Akemi ^g   Abdul Wahab, Alya ^a   Petrof, Gabriela ^a   Fong, Kenneth ^a   Harnchoowong, Sarawin ^a   Stone, Kristina L ^a   Harper, John I ^e   McLean, W H Irwin ^h   Simpson, Michael A ^a   Parsons, Maddy ^b   McGrath, John A ^a,h   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g ASAHIKAWA MEDICAL COLLEGE   (Japan)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; IMMUNOGLOBULIN E; IRON; MAGNESIUM; PROTEIN KINASE B; RETINOL; ZINC;

ACANTHOSIS; ALBUMIN BLOOD LEVEL; ALOPECIA; ARTICLE; BRONCHIOLITIS; CASE REPORT; CELL DIFFERENTIATION; CHEST INFECTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DERMATITIS; DIARRHEA; DRY SKIN; ELECTROLYTE DISTURBANCE; EOSINOPHIL COUNT; EPIDERMOLYSIS BULLOSA; EPITHELIUM; EROSION; EXOME; FAILURE TO THRIVE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERNATREMIA; HYPERTENSION; HYPOKALEMIA; IN VITRO STUDY; INFANT; INFLAMMATION; INHERITANCE; INNATE IMMUNITY; IRON BLOOD LEVEL; KERATINOCYTE; LOSS OF FUNCTION MUTATION; LUNG INFECTION; MAGNESIUM BLOOD LEVEL; MALE; MISSENSE MUTATION; NONHUMAN; PAPULE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; PUSTULE; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL; BIOPSY; FATALITY; GENETICS; HOMOZYGOTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SKIN;

BIOPSY; CELL DIFFERENTIATION; CHILD, PRESCHOOL; DERMATITIS; EPITHELIUM; FATAL OUTCOME; HOMOZYGOTE; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; KERATINOCYTES; MALE; MAP KINASE SIGNALING SYSTEM; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN;

EID: 84922391441     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.164     Document Type: Article

References (38)

1. Avraham R, Yarden Y (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 12:104-17
2. Adzhubei IA, Schmidt S, Peshkin L et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248-9
3. Blaydon DC, Biancheri P, Di WL et al. (2011) Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 365:1502-8
4. Blobel CP (2005) ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6:32-43
5. Chavanas S, Bodener C, Rochat A et al. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25 141-2
6. Dawson JP, Berger MB, Lin CC et al. (2005) Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol 25:7734-42
7. Dreux AC, Lamb DJ, Modjtahedi H et al. (2006) The epidermal growth factor receptors and their family of ligands: Their putative role in atherogenesis. Atherosclerosis 186:38-53
8. Fine JD, Eady RA, Bauer EA et al. (2008) The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol 58:931-50
9. Gschwind A, Fischer OM, Ullrich A (2004) The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4:361-70
10. Hansen LA, Alexander N, Hogan ME et al. (1997) Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol 150:1959-75
11. Inoue A, Saijo Y, Maemondo M et al. (2003) Severe acute interstitial pneumonia and gefitinib. Lancet 361:137-9
12. Jensen KB, Collins CA, Nascimento E et al. (2009) Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 4:427-39
13. Jost M, Kari C, Rodeck U (2000) The EGF receptor-an essential regulator of multiple epidermal functions. Eur J Dermatol 10:505-10
14. Jutten B, Rouschop KM (2014) EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle 13:42-51
15. Kumar A, Petri ET, Halmos B et al. (2008) Structure and clinical relevance of the epidermal growth factor receptor in human cancer. J Clin Oncol 26:1742-51
16. Lacouture ME (2006) Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 6:803-12
17. Lee CS, Kim IS, Park JB et al. (2006) The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis. Nat Cell Biol 8:477-84
18. Lichtenberger BM, Gerber PA, Holcmann M et al. (2013) Epidermal EGFR controls cutaneous host defense and prevents inflammation. Sci Transl Med 5:199ra111
19. Liu HB, Wu Y, Lv TF et al. (2013) Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with nonsmall cell lung cancer: a systematic review and meta-analysis. PLoS One 8:e55128
20. Macia E, Ehrlich M, Massol R et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839-50
21. Mascia F, Lam G, Keith C et al. (2013) Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy. Sci Transl Med 5:199ra110
22. Miettinen PJ, Berger JE, Meneses J et al. (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337-41
23. Nanba D, Toki F, Barrandon Y et al. (2013) Recent advances in the epidermal growth factor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation. J Dermatol Sci 72:81-6
24. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812-4
25. Ogiso H, Ishitani R, Nureki O et al. (2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775-87
26. Perrotte P, Matsumoto T, Inoue K et al. (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5: 257-65
27. Pastore S, Mascia F, Mariani V et al. (2008) The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128:1365-74
28. Peschon JJ, Slack JL, Reddy P et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282:1281-4
29. Petrof G, Mellerio JE, McGrath JA (2012) Desmosomal genodermatoses. Br J Dermatol 166:36-45
30. Repertinger SK, Campagnaro E, Fuhrman J et al. (2004) EGFR enhances early healing after cutaneous incisional wounding. J Invest Dermatol 123: 982-9
31. Rodeck U, Jost M, Kari C et al. (1997) EGF-R dependent regulation of keratinocyte survival. J Cell Sci 110:113-21
32. Schneider MR, Werner S, Paus R et al. (2008) Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology. Am J Pathol 173:14-24
33. Schneider MR, Wolf E (2009) The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218:460-6
34. Sibilia M, Kroismayr R, Lichtenberger BM et al. (2007) The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75:770-87
35. Sibilia M, Wagner EF (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234-8
36. Stoll C, Alembik Y, Tchomakov D et al. (2001) Severe hypernatraemic dehydration in an infant with Netherton syndrome. Genet Counsel 12:237-43
37. Threadgill DW, Dlugosz AA, Hansen LA et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230-4
38. Zhang Z, Xiao C, Gibson AM et al. (2014) EGFR signaling blunts allergeninduced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis. J Immunol 192:859-66